2 results
Approved WMORecruiting
This study will explore the safety, tolerability, PK, immunogenicity, PD, and preliminary efficacy of RO7428731, in participants with newly diagnosed and recurrent EGFRvIII-positive GBM.
Approved WMORecruiting
To determine B-cel en T-cel immunity im COVID-19 patients